Product Information
PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE) is a brand product labeled by Pfizer Inc., priced at $73.8241 per EA under NDC 00069531720. Its NADAC has been published 118 times since Feb 21, 2024.
Manufacturer
Pfizer Inc.NDC
00069531720
Classification
Brand
Dosage Form
KIT
Last Updated
5/20/2026
Approval Type
New Drug (NDA)
FDA Application
NDA217188On Market Since
10/18/2023
Price Statistics
The NADAC for PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE) has been published 118 times since Feb 21, 2024, and over the history we have for it it has risen 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $73.8241 per EA |
|---|---|
| All-time high | $73.8241 (May 20, 2026) |
| All-time low | $66.8532 (Apr 17, 2024) |
| 52-week high | $73.8241 |
| 52-week low | $71.6291 |
| Median price | $71.7615 |
| Average price | $70.9476 |
| Largest weekly change | +4.5% (Jul 3, 2024) |
| Weeks tracked | 118 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE)?
The current National Average Drug Acquisition Cost (NADAC) for PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE), manufactured by Pfizer Inc., is $73.8241 per EA (NDC 00069531720), effective May 20, 2026.
How has the price of PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE) changed over time?
Over the history we have for it, the NADAC for PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE) has risen 9.9%. It has been tracked across 118 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE)?
Since Feb 21, 2024, the NADAC for PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE) has ranged from a low of $66.8532 (Apr 17, 2024) to a high of $73.8241 (May 20, 2026), with a median of $71.7615 per EA.
Are there cheaper alternatives to PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE)?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, PAXLOVID 300-100 MG DOSE PACK, is $49.2332 per EA — about 33% below PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE).
Who manufactures PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE)?
PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE) (NDC 00069531720) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification